SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer informs about board meeting

01 Sep 2022 Evaluate
Pfizer has informed that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, September 6, 2022, to consider declaration of Interim Dividend for the Financial Year ending March 31, 2023. Further informed that, Pursuant to the 'Pfizer - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders' the Trading Window of the Company shall remain closed from Thursday, September 1, 2022 (close of business) till 48 hours after the 
declaration of Interim Dividend, September 8, 2022 (close of business).

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4794.05 -17.00 (-0.35%)
11-May-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.45
Dr. Reddys Lab 1275.00
Cipla 1333.20
Zydus Lifesciences 932.75
Lupin 2237.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×